Canopy Growth To Expand Investment In US Hemp Industry
4 Reasons to Keep Buying Pot Stocks in 2019
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending 31 December 2018 and Host Conference Call on 26 February 2019
Colombia Authorizes First Cannabis Export To Canada: 'This Event Has Been Two Years In The Making'
4 Marijuana Stocks Leading The Market Surge On Thursday (2/7/19)
Watch These Marijuana Stocks Enjoy A Boost From Today's Headlines
4 Marijuana Stocks Gaining Speed On Thursday (2/7/19)
Buy the Dip in Marijuana Stocks & ETF?
Edited Transcript of PLUS earnings conference call or presentation 6-Feb-19 9:30pm GMT
Should You Buy Cronos Group Stock on the Dip?
Marijuana ETF Joins Billion Dollar Club
These 4 Marijuana Stocks Could Test February Highs
Should Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Be Your Next Stock Pick?
Zynerba Stock Is Marijuana-Adjacent Play Worth a Look
Think Opportunistically While You Navigate This Action
Cannabis stocks fall across the board as Aphria rejects bid, crackdown on CBD spreads
GrowGeneration Acquires The Assets Of Palm Springs Hydroponics
Is a Beat in Store for Molina Healthcare (MOH) Q4 Earnings?
Cannabis Plays Going Higher
Chipotle’s Stock Price Rose Due to Strong Q4 Earnings
Chipotle's (CMG) Shares Soar on Q4 Earnings & Revenue Beat
Canopy Growth’s Margins: Analysts’ Expectations
Yum! Brands (YUM) Q4 Earnings & Revenues Miss Estimates
Thursday’s Vital Data: Electronic Arts, Activision and Cronos Group
Watch These 4 Marijuana Stocks On Thursday (2/7/19)
InvestmentPitch Media Video Discusses Weekend Unlimited's Shareholder Update by Paul Chu, President and CEO - Video News Alert on Investmentpitch.com
Why HEXO Stock Rocketed Higher in January
Auxly Announces Termination of FSD Pharma Joint Venture
Supreme Cannabis Expands Domestic Distribution to Eight Provinces
Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media
Three of the Biggest Beneficiaries of the 2019 US Farm Bill
Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics
Wize Pharma, Inc. Signs Joint Venture With Cannabics, to Research and Develop Cannabinoid Formulations to Treat Ophthalmic Conditions